Online Canadian Pharmacy - Best online drugs choice
Ann Pharmacy All products
Ann Pharmacy bestsellers
Ann Pharmacy FAQ
Ann Pharmacy contacts
Your cart: $0.00 (0 items)
Proceed to Checkout
We accept
VISA MasterCard AMEX Diners JCB eCHECK
Search drugs by name:
PRODUCT LIST
Pharmacy Home > PRIVACY POLICY
Top products
Privacy policy

Face any abuse or violations of the AnnPharmacy service, please send us a message. We will consider it with you and make every effort to remedy the situation. Do not hesitate to contact us with any questions or concerns regarding this privacy policy.

Web Site Information Collection

Our Web server automatically recognizes only the consumer's domain name or IP address without the e-mail address. Unless otherwise stated on our web site, we collect only the domain name or IP address of visitors to our Web page, the e-mail addresses of those who communicate with us via e-mail, aggregate information on what pages consumers access or visit, user-specific information on what pages consumers access or visit, information volunteered by the consumer, such as survey information and registrations to access portions of the site and their related services or to set up a AnnPharmacy account.

Use of Web Site Information Collected

The information we collect is used to create an aggregate demographic profile of our user base so that we can improve the content and services of our Web site and provide aggregate information to potential advertisers (no individual information is provided to any third-party without your consent), to customize the content and/or layout of our page for each individual visitor, to notify consumers about updates to our Web site and services, to send visitors our opt-in e-mail newsletter(s) (if requested by the visitor), to provide users with the products and/or services for which they signed-up or registered which may include sending service disruption notices or other service- or product-related information via e-mail, and is not shared with other organizations for commercial purposes without the visitor's consent.

Use of Your Email Information

AnnPharmacy is not an email list rental service and does not rent or sell any email addresses or other contact information that you provide.

E-mail and Direct Response Contact

All of our direct response methods are opt-in. If you subscribed to our e-mail newsletter(s) but do not want to receive it in the future, please follow the "unsubscribe" instructions contained in the newsletter(s).

Postal Address Collection and Use

Your supply us with your postal address on-line will provide you with the product for which you sent us your address. We will use your telephone number to contact you with information regarding your account, orders your have placed, or with information regarding your inquiry. Your contact information will not be sent to any third parties without your permission.

Cookies

We, and some of our partners providing some of the services and products on our site, use cookies to record session information: past activity at a site in order to provide better service when visitors return to our site, customize Web page content based on visitors' browser type or other information that the visitor sends, and to enable access to specific areas on the web site.

Changes to Privacy Policy

Sometimes new policy changes appear at our Web site's Privacy Policy page. So check back at our Web site's Privacy Policy page periodically.

© 2002-2009 annpharmacy.com, Inc. All Rights Reserved.

Last Updated: April 20, 2008

Erection packs

Pharmacy News


The FDA has approved two additional uses for rituximab (Rituxan, Genen-tech/Biogen Idec) for patients with CD20-positive, B-cell non-Hodgkin’s lym-phoma (NHL): as a first-line treatment of previously untreated patients with fol-licular NHL in combination with cyclo-phosphamide, vincristine, and predni-solone (CVP) chemotherapy, and as a treatment for low-grade NHL in patients with stable disease or who have [...]

Coagulation factor VIIa (recombinant) (NovoSeven, Novo Nordisk) is the first recombinant therapy to be approved for the treatment of bleeding episodes and for the prevention of bleeding in patients with acquired hemophilia who are undergoing invasive surgical procedures. First introduced in 1999, NovoSeven is currently indicated for the treatment of bleeding episodes in hemophilia A or [...]

Posaconazole oral suspension (Noxafil, Schering-Plough) is now approved for patients with oropharyngeal candi-diasis, including infections refractory to itraconazole and/or fluconazole. cheap celebrex

Sitagliptin generic phosphate (Januvia, Merck), the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors, enhances the body’s own ability to lower elevated blood glucose levels. The FDA approved the tablets for use in addition to diet and exercise to improve blood sugar levels in patients with type-2 diabetes; the drug [...]

© Copyright AnnPharmacy, 2002-2009.